Detection of I491F and V170F rpoB mutations associated with misdiagnosis of rifampicin resistance among patients with drug-susceptible tuberculosis treatment failure, Myanmar, 2022.

Saved in:
Bibliographic Details
Title: Detection of I491F and V170F rpoB mutations associated with misdiagnosis of rifampicin resistance among patients with drug-susceptible tuberculosis treatment failure, Myanmar, 2022.
Authors: Ei PW; Department of Medical Research, Yangon, Republic of the Union of Myanmar. Electronic address: winei.mm@gmail.com., Htwe MM; Department of Medical Research, Yangon, Republic of the Union of Myanmar., Nyunt MH; Department of Medical Research, Yangon, Republic of the Union of Myanmar., Mon AS; Department of Medical Research, Yangon, Republic of the Union of Myanmar., Myint Z; National Tuberculosis Program (Yangon Branch), Department of Public Health, Yangon, Republic of the Union of Myanmar., Nyunt WW; National TB Reference Laboratory, Yangon, Republic of the Union of Myanmar., Win SM; Department of Medical Research, Yangon, Republic of the Union of Myanmar., Aung S; Department of Medical Research, Yangon, Republic of the Union of Myanmar., Thwe WM; Department of Medical Research, Yangon, Republic of the Union of Myanmar., Aung WW; Department of Medical Research, Yangon, Republic of the Union of Myanmar.
Source: Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2025 Mar; Vol. 41, pp. 169-172. Date of Electronic Publication: 2025 Jan 08.
Publication Type: Journal Article
Journal Info: Publisher: Published by Elsevier Ltd. on behalf of International Society of Chemotherapy for Infection and Cancer Country of Publication: Netherlands NLM ID: 101622459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-7173 (Electronic) Linking ISSN: 22137165 NLM ISO Abbreviation: J Glob Antimicrob Resist Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2213-7173
DOI:10.1016/j.jgar.2024.12.026